Related Experiment Videos
Aberrant plasticity in Alzheimer's disease
1Department of Neurology, Kyoto Prefectural University of Medicine, Japan.
Neuroreport
|June 25, 1999
Summary
Alzheimer's disease (AD) shows frontal lobe preservation, with [11C]diacylglycerol PET revealing compensatory plasticity in these areas. This suggests a potential mechanism to counteract posterior region damage in AD patients.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Alzheimer's disease (AD) is characterized by region-specific neurodegeneration, primarily affecting temporal and parietal lobes while sparing frontal lobes until late stages.
- Understanding frontal lobe function is crucial for comprehending AD's progression and potential therapeutic targets.
Purpose of the Study:
- To evaluate frontal lobe function in Alzheimer's disease (AD) patients using [11C]diacylglycerol Positron Emission Tomography (PET).
- To investigate the potential for compensatory plastic processes in the frontal lobes of AD patients.
Main Methods:
- Positron Emission Tomography (PET) imaging was performed using [11C]diacylglycerol in eight AD patients and six age-matched controls.
- [18F]fluorodeoxyglucose (FDG) PET was also utilized to assess regional cerebral metabolic glucose utilization (CMRGlc).
Main Results:
- [11C]Diacylglycerol PET scans in AD patients showed significant, spotty incorporation primarily in frontal association areas.
- FDG PET revealed decreased CMRGlc in parietotemporal association areas of AD patients, consistent with cognitive impairment.
- The observed [11C]diacylglycerol uptake in frontal lobes suggests a compensatory plastic response.
Conclusions:
- Frontal lobes may exhibit compensatory plasticity in Alzheimer's disease, potentially in response to neurodegeneration in posterior regions.
- This compensatory mechanism in the frontal lobes could play a role in maintaining cognitive function despite widespread AD pathology.